CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes

Open access
The DCCT/EDIC Research Group · 2017 · New England Journal of Medicine

Abstract

BACKGROUND: In patients who have had type 1 diabetes for 5 years, current recommendations regarding screening for diabetic retinopathy include annual dilated retinal examinations to detect proliferative retinopathy or clinically significant macular edema, both of which require timely intervention to preserve vision. During 30 years of the Diabetes Control and Complications Trial (DCCT) and its longitudinal follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, retinal photography was performed at intervals of 6 months to 4 years. METHODS: We used retinal photographs from the DCCT/EDIC study to develop a rational screening frequency for retinopathy. Markov modeling was used to determine the likelihood of progression to proliferative diabetic retinopathy or clinically significant macular edema in patients with various initial retinopathy levels (no retinopathy or mild, moderate, or severe nonproliferative diabetic retinopathy). The models included recognized risk factors for progression of retinopathy. RESULTS: Overall, the probability of progression to proliferative diabetic retinopathy or clinically significant macular edema was limited to approximately 5% between retinal screening examinations at 4 years among patients who had no retinopathy, 3 years among those with mild retinopathy, 6 months among those with moderate retinopathy, and 3 months among those with severe nonproliferative diabetic retinopathy. The risk of progression was also closely related to mean glycated hemoglobin levels. The risk of progression from no retinopathy to proliferative diabetic retinopathy or clinically significant macular edema was 1.0% over 5 years among patients with a glycated hemoglobin level of 6%, as compared with 4.3% over 3 years among patients with a glycated hemoglobin level of 10%. Over a 20-year period, the frequency of eye examinations was 58% lower with our practical, evidence-based schedule than with routine annual examinations, which resulted in substantial cost savings. CONCLUSIONS: Our model for establishing an individualized schedule for retinopathy screening on the basis of the patient's current state of retinopathy and glycated hemoglobin level reduced the frequency of eye examinations without delaying the diagnosis of clinically significant disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; DCCT/EDIC ClinicalTrials.gov numbers, NCT00360893 and NCT00360815 .).

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa1612836

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Wang JK, 2015, Eye Sci, 30, 176

Cited by

See all 141

Metadata

Authors
The DCCT/EDIC Research Group
Affiliations
Harvard University (US)
Corresponding author
The DCCT/EDIC Research Group
Venue
New England Journal of Medicine
Published
2017-04-20
Volume
376
Issue
16
Pages
1507-1516
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2612354450
Cited by
141
References
35
Citations by year
2026: 10 · 2025: 11 · 2024: 11 · 2023: 15 · 2022: 20 · 2021: 14 · 2020: 20 · 2019: 14 · 2018: 18 · 2017: 8
FWCI
16.00
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5u01dk094157-13, UL1TR001863)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK036836, P30DK017047)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
diabetic retinopathy, type 1 diabetes, proliferative diabetic retinopathy, clinically significant macular edema, fundus photography, HbA1c, retinopathy progression, Markov model, cost reduction, DCCT/EDIC
MeSH terms
Adolescent, Adult, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Follow-Up Studies, Glycated Hemoglobin, Humans, Macular Edema, Markov Chains, Photography, Retina, Risk Factors, Visual Acuity, Practice Guidelines as Topic, Disease Progression, Evidence-Based Medicine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. https://app.cochat.ai/papers/10.1056/nejmoa1612836
The paper
The DCCT/EDIC Research Group. (2017). Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1612836

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.